Detalles de la búsqueda
1.
Nomograms including the controlling nutritional status score in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation for prediction survival: a retrospective analysis.
Br J Nutr
; 128(10): 1966-1974, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34881693
2.
Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
Int J Hyperthermia
; 39(1): 437-445, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35249443
3.
Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
Eur Radiol
; 31(5): 3053-3064, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33175203
4.
Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors.
Int J Hyperthermia
; 38(1): 437-446, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724137
5.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
EClinicalMedicine
; 72: 102622, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745965
6.
Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Sci Rep
; 13(1): 1808, 2023 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720974
7.
Association between depressive symptoms and lung function in the United States adults without pulmonary diseases: A cross-sectional study from NHANES.
J Affect Disord
; 325: 787-793, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638969
8.
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma.
Hepatol Int
; 17(3): 753-764, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038024
9.
Complete Response After Pre-Operative Transcatheter Arterial Chemoembolization for Unresectable Primary Hepatic Neuroendocrine Tumour: A Case Report and Literature Review.
Front Oncol
; 12: 893403, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35692743
10.
The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization.
Clin Res Hepatol Gastroenterol
; 46(4): 101878, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35151909
11.
A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Cardiovasc Intervent Radiol
; 45(1): 43-53, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34561739
12.
Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.
Front Immunol
; 13: 929141, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35990634
13.
Safety and efficacy of ultrasound-guided percutaneous coaxial core biopsy of pancreatic lesions: a retrospective study.
J Ultrasound
; 24(3): 269-277, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32705502
14.
A multicenter, hospital-based and non-inferiority study for diagnostic efficacy of automated whole breast ultrasound for breast cancer in China.
Sci Rep
; 11(1): 13902, 2021 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34230562
15.
Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.
J Gastrointest Oncol
; 12(6): 2930-2942, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35070419
16.
Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study.
J Hepatocell Carcinoma
; 8: 837-850, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34350139
17.
Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
J Gastrointest Oncol
; 12(2): 735-750, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34012662
18.
Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study.
Eur J Radiol
; 138: 109623, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33711573
19.
Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation.
Cardiovasc Intervent Radiol
; 44(10): 1551-1560, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036405
20.
Prognostic significance of controlling nutritional status score-based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation.
J Gastrointest Oncol
; 11(5): 1024-1039, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33209495